Farther Finance Advisors, LLC Summit Therapeutics Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 57,282 shares of SMMT stock, worth $1.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,282
Previous 55,236
3.7%
Holding current value
$1.04 Million
Previous $1.14 Billion
12.21%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
262Shares Held
93.5MCall Options Held
4.72MPut Options Held
4.03M-
Baker Bros. Advisors LP New York, NY33.7MShares$615 Million5.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$144 Million0.0% of portfolio
-
State Street Corp Boston, MA6.36MShares$116 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.54MShares$82.8 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.67B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...